HopeStage
Back to all studies
CompletedNCT01429272

Minocycline and Aspirin for Depression Related to Bipolarity

About this titleRead the official source — NCT01429272
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Wichita and 2 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2011
Recruitment status
Completed
Enrollment listed in the registry
99
Sponsor
Laureate Institute for Brain Research, Inc.
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01429272
Official title
Show the full official title

Minocycline and Aspirin in the Treatment of Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Wichita · Tulsa

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Laureate Institute for Brain Research, Inc., a research institute.

Did this study involve medication?

Yes. The study involved medication, including Minocycline, Aspirin and placebo.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies